CSS
OCUL icon

Cubist Systematic Strategies’s Ocular Therapeutix OCUL Stock Holding History

Cubist Systematic Strategies’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$5.45M Buy
+466,179
New +$5.57M 0.03% 902
2025
Q2 		– Sell
-137,871
Closed -$1.01M – 3359
2025
Q1 		$1.01M Buy
+137,871
New +$1.06M 0.01% 1812
2024
Q2 		– Sell
-336,132
Closed -$3.06M – 3725
2024
Q1 		$3.06M Buy
+336,132
New +$2.39M 0.02% 1318
2023
Q2 		– Sell
-42,989
Closed -$227K – 4066
2023
Q1 		$227K Buy
+42,989
New +$204K ﹤0.01% 3168
2022
Q4 		– Sell
-48,210
Closed -$200K – 4498
2022
Q3 		$200K Buy
48,210
+8,314
+21% +$41.9K ﹤0.01% 3762
2022
Q2 		$160K Buy
39,896
+6,656
+20% +$25.1K ﹤0.01% 3788
2022
Q1 		$165K Sell
33,240
-149,994
-82% -$831K ﹤0.01% 3099
2021
Q4 		$1.28M Buy
183,234
+91,865
+101% +$713K 0.01% 1731
2021
Q3 		$914K Buy
91,369
+67,123
+277% +$754K 0.01% 1591
2021
Q2 		$344K Buy
+24,246
New +$369K ﹤0.01% 2252
2021
Q1 		– Sell
-17,487
Closed -$362K – 2934
2020
Q4 		$362K Sell
17,487
-11,351
-39% -$169K 0.01% 1942
2020
Q3 		$219K Buy
28,838
+10,120
+54% +$84K ﹤0.01% 2102
2020
Q2 		$156K Buy
+18,718
New +$124K ﹤0.01% 2110

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Cubist Systematic Strategies's OCUL Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Ocular Therapeutix (OCUL) in Q3 2025: 466,179 shares worth $5.45M. The stake represents 0.03% of the portfolio and ranks #902 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in OCUL as recently as Q1 2025.

Cubist Systematic Strategies first reported a position in OCUL in Q2 2020 and has held it in 13 quarters since. 216 funds tracked by Wall St. Rank hold OCUL as of Q3 2025.

  • Cubist Systematic Strategies held 466,179 shares of Ocular Therapeutix worth $5.45M as of Q3 2025.
  • Ocular Therapeutix was a new Cubist Systematic Strategies position in Q3 2025.
  • Ocular Therapeutix made up 0.03% of Cubist Systematic Strategies's portfolio in Q3 2025, its #902 holding.
  • Cubist Systematic Strategies first reported a position in Ocular Therapeutix in Q2 2020 and has held it in 13 quarters since.
  • 216 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.